MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$1,069,400K
(-74.35%↓ Y/Y)
Accounts payable and
accrued liabilities
$395,100K
(341.45%↑ Y/Y)
Loss on impairment
and intangible...
$186,900K
Stock-based compensation
(note 2 and note 16)
$158,100K
(-2.59%↓ Y/Y)
Depreciation and
amortization
$156,600K
(0.90%↑ Y/Y)
Inventories
-$50,700K
(-119.80%↓ Y/Y)
Non-cash operating lease
cost
$25,900K
(-6.83%↓ Y/Y)
Long-term prepaid
royalties (note 3)
-$8,300K
(0.00%↑ Y/Y)
Other
-$7,700K
(58.15%↑ Y/Y)
Net cash provided by
operating activities
$1,595,200K
(194.15%↑ Y/Y)
Canceled cashflow
$463,500K
Net (decrease)
increase in cash, cash...
-$119,300K
(-106.24%↓ Y/Y)
Canceled cashflow
$1,595,200K
Proceeds from stock plans
$174,100K
(-3.01%↓ Y/Y)
Proceeds from sales and
maturities of...
$2,816,000K
(251.96%↑ Y/Y)
Proceeds from sale of
non-core product group...
$78,800K
(-97.99%↓ Y/Y)
Proceeds from sales and
maturities of...
$62,100K
(8.00%↑ Y/Y)
Income taxes
-$141,800K
(24.05%↑ Y/Y)
Deferred income taxes
$117,600K
(-63.64%↓ Y/Y)
Intellectual property
agreement accrual
-$76,500K
(-107.88%↓ Y/Y)
Other
$34,500K
(61.21%↑ Y/Y)
Gain on sale of
product groups (note 5)
$33,900K
(-98.99%↓ Y/Y)
Prepaid expenses and
other current assets
$23,700K
(204.41%↑ Y/Y)
Accounts and other
receivables, net
$23,000K
(118.98%↑ Y/Y)
Change in fair value of
contingent consideration...
-$12,500K
Net cash used in
financing activities
-$956,800K
(2.67%↑ Y/Y)
Canceled cashflow
$174,100K
Net cash (used in)
provided by investing...
-$712,900K
(-130.82%↓ Y/Y)
Effect of currency
exchange rate changes on...
-$44,800K
(-216.06%↓ Y/Y)
Canceled cashflow
$2,956,900K
Purchases of treasury
stock
$893,400K
(-22.94%↓ Y/Y)
Purchase of remaining
noncontrolling interest in...
$233,700K
Other
-$3,800K
(-22.58%↓ Y/Y)
Purchases of
available-for-sale investments...
$3,091,800K
(243.57%↑ Y/Y)
Capital expenditures
$260,200K
(3.09%↑ Y/Y)
Issuances of notes
receivable
$140,900K
(123.65%↑ Y/Y)
Investments in
unconsolidated entities (note...
$64,800K
Purchases of
held-to-maturity investments...
$43,300K
(-5.66%↓ Y/Y)
Payment for working
capital adjustment and...
$36,300K
Payments for acquisition
options (note 9)
$25,100K
(-45.67%↓ Y/Y)
Other
$7,400K
(-89.85%↓ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
logo (34)-svg
Edwards Lifesciences Corp (EW)
logo (34)-svg
Edwards Lifesciences Corp (EW)